Boxer Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Boxer Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-375,000	Closed	-$19.8M	–	66
2026 Q1	$19.8M	Hold	375,000	–	–	2.6%	8
2025 Q4	$15.2M	Buy	+375,000	New	+$8.67M	3.32%	8
2025 Q1	–	Sell	-752,000	Closed	-$4.17M	–	56
2024 Q4	$4.17M	Buy	+752,000	New	+$5.09M	0.35%	42

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boxer Capital Management's TERN Position: Q2 2026 in Review

Boxer Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 375,000 shares — an estimated $19.8M sold.

Boxer Capital Management first reported a position in TERN in Q4 2024 and held it in 3 quarters. The position peaked at $19.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Boxer Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Boxer Capital Management sold 375,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $19.8M.
Boxer Capital Management first reported a position in Terns Pharmaceuticals in Q4 2024 and held it in 3 quarters.
Boxer Capital Management's Terns Pharmaceuticals position peaked at $19.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.